The aim was to evaluate the efficacy and safety of two recombinant factor VIIa (rFVIIa) dose regimens for treating haemarthroses in patients with congenital haemophilia A or B and inhibitors...
Keywords: Recombinant FVIIa, Haemophilia, inhibitor, high-dose, home treatment
04/2006 | Thrombosis and Haemostasis, Schattauer